Marco Rubio Steps Down as Acting U.S. Archivist Amid Federal Law Limits 
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit 
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages 
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business 
New York Legalizes Medical Aid in Dying for Terminally Ill Patients 
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges 
Pentagon Ends Military Education Programs With Harvard University 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding 
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Trump Allows Commercial Fishing in Protected New England Waters 
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions 
Former President Donald Trump’s administration was highly criticized for their response to the COVID-19 pandemic with reports surfacing of conflicts between experts and administration officials behind the scenes.
A new report reveals the Trump administration had given $1.3 billion to a company producing syringes for the vaccines, but no syringes were produced.
Despite having millions of COVID-19 vaccine doses already administered recently, a report has surfaced that the Trump administration gave a $1.3 billion contract to ApiJect Systems Corp. to make the syringes needed to administer the vaccines. However, no syringes have been made, and the company’s supposed plans to establish a factory with 650 jobs open remains to be seen. The syringes also have yet to gain approval from the federal government before it could be produced as well.
Nevertheless, the need for ApiJect’s syringes has now declined especially as millions of Americans have already been vaccinated. This now leaves the contracts and federal loans in the air.
In a statement to NBC News, ApiJect said it “is working with several vaccine pharmaceutical companies to conduct the testing and regulatory reviews of the COVID-19 vaccines in the ApiJect syringe.”
A spokesperson for Pfizer, however, said that even if the ApiJect syringes received all the approvals from the federal government, it would not affect their output or their process. Moderna and Johnson & Johnson did not comment.
In other news, Trump has touted the wall closing off the southern border and keeping migrants from crossing as one of his campaign pledges, an effort that Joe Biden shut down as soon as he took office. However, as the Biden administration tackles the influx of migrants seeking to make it to the US, US Border Patrol officials have often discovered ladders left alongside the wall. The officials have also had to call for assistance in Hidalgo, Texas, to clear out the discarded ladders that migrants used to scale the wall.
According to local artist and activist Scott Lowry, the use of ladders to climb the wall and cross the border proves the uselessness of the wall that Trump had planned. “Unlike the wall, these ladders are functional,” said Lowry.
